Syngene Int. - Syngene International Share Price

  • 731.956.21 (0.86%)
  • Volume: 9,98,466
  • Closed
  • Last Updated On: 05 Jul, 2024, 03:57 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Syngene Int. - Syngene ...

  • 731.956.21 (0.86%)
  • Volume: 9,98,466
Advertisment

Syngene Int. share price insights

View All

  • Company has spent 1.35% of its operating revenues towards interest expenses and 25.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 25.01% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

  • Stock generated 25.01% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Syngene International Ltd. share price moved up by 0.86% from its previous close of Rs 725.75. Syngene International Ltd. stock last traded price is 731.95

    Share PriceValue
    Today/Current/Last731.95
    Previous Day725.75725.35

InsightsSyngene Int.

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		57.70
    EPS - TTM
    (₹)    		12.69
    MCap
    (₹ Cr.)    		29,425.49
    Sectoral MCap Rank
    		17
    PB Ratio
    (x)    		6.85
    Div Yield
    (%)    		0.17
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.40
    3 Months0.89
    6 Months0.59
    1 Year0.56
    3 Years0.69

    		0.40
    VWAP
    (₹)    		730.53
    52W H/L
    (₹)
    860.25 / 607.65

    Syngene Int. Share Price Returns

    1 Day0.86%
    1 Week3.09%
    1 Month8.99%
    3 Months0.34%
    1 Year-3.05%
    3 Years24.6%
    5 Years123.29%

    ET Stock ScreenersTop Score Companies

    Check whether Syngene Int. belongs to analysts' top-rated companies list?

    View Stock Screeners

    Syngene Int. News & Analysis

    View all Syngene Int. Share News & Announcements

    Syngene Int. Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Syngene Int. Share Recommendations

    Recent Recos

    HOLD

    Current

    Mean Recos by 8 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy

    That's all for Syngene Int. recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy2222
    Buy2222
    Hold---1
    Sell3222
    Strong Sell122-
    # Analysts8887
    View all Stock Recommendations

    Syngene Int. Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 1.35% of its operating revenues towards interest expenses and 25.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income933.00882.80931.70831.701,017.20
      Total Income Growth (%)5.69-5.2512.02-18.2426.66
      Total Expenses711.10733.80768.00698.30775.90
      Total Expenses Growth (%)-3.09-4.459.98-10.0019.46
      EBIT221.90149.00163.70133.40241.30
      EBIT Growth (%)48.93-8.9822.71-44.7257.10
      Profit after Tax (PAT)188.60111.50116.5093.40178.70
      PAT Growth (%)69.15-4.2924.73-47.7362.90
      EBIT Margin (%)23.7816.8817.5716.0423.72
      Net Profit Margin (%)20.2112.6312.5011.2317.57
      Basic EPS (₹)4.702.782.902.334.46
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income880.00820.70851.70738.701,017.20
      Total Income Growth (%)7.23-3.6415.30-27.3826.55
      Total Expenses661.10689.70712.40641.10766.10
      Total Expenses Growth (%)-4.15-3.1911.12-16.3217.72
      EBIT218.90131.00139.3097.60251.10
      EBIT Growth (%)67.10-5.9642.73-61.1364.12
      Profit after Tax (PAT)189.8099.80101.6075.30189.00
      PAT Growth (%)90.18-1.7734.93-60.1672.60
      EBIT Margin (%)24.8815.9616.3613.2124.69
      Net Profit Margin (%)21.5712.1611.9310.1918.58
      Basic EPS (₹)4.732.492.531.884.71
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3,579.203,263.802,657.002,248.902,093.50
      Total Revenue Growth (%)9.6622.8418.157.4210.14
      Total Expenses2,947.302,670.202,141.901,814.701,647.90
      Total Expenses Growth (%)10.3824.6718.0310.1210.95
      Profit after Tax (PAT)510.00464.40395.80404.90412.10
      PAT Growth (%)9.8217.33-2.25-1.7524.28
      Operating Profit Margin (%)19.4620.0020.7021.1423.86
      Net Profit Margin (%)14.6114.5415.1918.5320.48
      Basic EPS (₹)12.7111.599.9410.1810.38
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3,291.103,264.402,654.202,244.002,093.50
      Total Revenue Growth (%)0.8222.9918.287.1910.14
      Total Expenses2,722.702,663.502,141.801,811.601,649.10
      Total Expenses Growth (%)2.2224.3618.239.8510.94
      Profit after Tax (PAT)466.50473.00393.80403.70411.50
      PAT Growth (%)-1.3720.11-2.45-1.9024.43
      Operating Profit Margin (%)18.6620.2320.6221.1123.80
      Net Profit Margin (%)14.5614.8115.1318.5220.45
      Basic EPS (₹)11.6211.819.8910.1510.36

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets6,151.605,831.005,563.804,883.204,162.90
      Total Assets Growth (%)5.504.8013.9417.3012.40
      Total Liabilities1,893.802,213.002,266.202,061.801,987.10
      Total Liabilities Growth (%)-14.42-2.359.913.7614.52
      Total Equity4,257.803,618.003,297.602,821.402,175.80
      Total Equity Growth (%)17.689.7216.8829.6710.54
      Current Ratio (x)1.712.041.801.591.05
      Total Debt to Equity (x)0.030.160.240.270.14
      Contingent Liabilities837.20805.50664.10595.50646.00
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets5,833.905,848.005,560.804,877.504,162.00
      Total Assets Growth (%)-0.245.1614.0117.1912.42
      Total Liabilities1,642.402,229.102,268.802,059.201,987.90
      Total Liabilities Growth (%)-26.32-1.7510.183.5914.57
      Total Equity4,191.503,618.903,292.002,818.302,174.10
      Total Equity Growth (%)15.829.9316.8129.6310.52
      Current Ratio (x)1.692.111.791.591.05
      Total Debt to Equity (x)0.030.160.240.270.14
      Contingent Liabilities798.70805.50664.10595.50646.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 495.6 cr for investing activities which is an YoY decrease of 24.5%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities1,042.10823.50580.60701.20677.10
      Net Cash used in Investing Activities-495.60-656.40-611.50-628.10-428.40
      Net Cash flow from Financing Activities-551.40-342.50-31.3058.00-225.50
      Net Cash Flow-3.80-172.30-61.50130.3027.80
      Closing Cash & Cash Equivalent85.7089.50261.80323.30193.00
      Closing Cash & Cash Equivalent Growth (%)-4.25-65.81-19.0267.5116.83
      Total Debt/ CFO (x)0.140.701.361.100.46
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities913.40838.40582.20698.00677.40
      Net Cash used in Investing Activities-383.50-688.20-611.50-628.10-428.40
      Net Cash flow from Financing Activities-536.30-340.20-31.3058.00-225.50
      Net Cash Flow-5.50-186.90-59.90127.1028.10
      Closing Cash & Cash Equivalent66.6072.10259.00318.90191.80
      Closing Cash & Cash Equivalent Growth (%)-7.63-72.16-18.7866.2717.17
      Total Debt/ CFO (x)0.160.691.361.110.46

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)11.9712.8312.0014.3518.94
      Return on Capital Employed (%)13.5613.7512.4312.3118.30
      Return on Assets (%)8.297.967.118.299.89
      Interest Coverage Ratio (x)23.4122.2435.2226.5820.22
      Asset Turnover Ratio (x)0.580.560.500.480.51
      Price to Earnings (x)55.5651.5560.6153.7623.47
      Price to Book (x)6.636.607.257.704.44
      EV/EBITDA (x)25.1523.7828.5029.6913.85
      EBITDA Margin (%)31.6731.4832.5933.7134.76
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)11.1213.0711.9614.3218.92
      Return on Capital Employed (%)12.6214.4212.3912.2718.26
      Return on Assets (%)7.998.087.088.279.88
      Interest Coverage Ratio (x)32.7722.2435.1126.5213.84
      Asset Turnover Ratio (x)0.550.560.500.4848.33
      Price to Earnings (x)60.6150.5160.9854.0523.53
      Price to Book (x)6.736.597.277.714.44
      EV/EBITDA (x)28.7823.8128.6029.7713.88
      EBITDA Margin (%)30.1831.4732.5233.7034.70

    Financial InsightsSyngene Int.

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 1.35% of its operating revenues towards interest expenses and 25.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 495.6 cr for investing activities which is an YoY decrease of 24.5%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Syngene Int. Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Syngene Int.

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Syngene Int.

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Syngene Int.

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Syngene Int. Peer Comparison

    • Syngene Int. Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 25.01% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 25.01% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 25.01% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 25.01% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Syngene Int.57.706.9111.9713.568.2916.5719.4614.6112.711.710.030.14
          Glenmark Pharma-23.194.81-19.1317.01-10.454.7512.30-12.13-53.221.280.13-3.73
          Gland Pharma39.233.478.8512.507.2417.3020.4513.6346.904.040.040.32
          Ipca Labs55.293.928.6412.444.9312.4814.126.8621.572.350.221.47
          Ajanta Pharma34.978.0022.8729.9517.5913.6226.6319.3964.823.050.000.00
          Add More
          Annual Ratios (%)

          Choose from Peers

          • J B Chemicals
          • Aarti Inds
          • Laurus Labs
          • Natco Pharma
          • Piramal Pharma

          Choose from Stocks

            See All Parameters

          Peers InsightsSyngene Int.

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Syngene Int. Shareholding Pattern

            • QOQ Change

            • Total Shareholdings

            • Loading...
              Showing Syngene Int. Shareholding as on 31 Mar 2024
              Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
              Promoters54.7954.7954.7954.80
              Pledge0.000.000.000.00
              FII20.9121.2023.5523.18
              DII15.7814.6211.7011.20
              Mutual Funds12.5911.939.098.58
              Others8.519.399.9510.82
            • Showing Shareholding as on 31 Mar 2024
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters22,02,83,69754.79 %0.00
              Pledge00.00 %0.00
              FII8,41,15,88420.91 %-0.28
              DII6,34,09,33915.78 %1.15
              MF5,06,07,03512.59 %0.66
              Others3,42,06,0808.51 %-0.87

            MF Ownership

            MF Ownership as on 31 May 2024

            View all Mutual Fund Schemes

            Top Searches:

            Syngene Int. News Syngene Int. Quarterly Results Syngene Int. Dividend Syngene Int. Q1 ResultsSyngene Int. Q2 ResultsSyngene Int. Q3 ResultsSyngene Int. Q4 Results

            Corporate Actions

            • Syngene Int. Board Meeting/AGM

            • Syngene Int. Dividends

            • Others
            • Meeting DateAnnounced onPurposeDetails
              Jul 24, 2024Jun 28, 2024Board MeetingQuarterly Results
              Apr 24, 2024Apr 01, 2024Board MeetingAudited Results & Final Dividend
              Jan 25, 2024Dec 26, 2023Board MeetingQuarterly Results
              Oct 17, 2023Oct 06, 2023Board MeetingQuarterly Results
              Jul 26, 2023Jul 13, 2023Board MeetingQuarterly Results
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final12%1.25Jun 28, 2024Apr 24, 2024
              Final5%0.5Jun 30, 2023Apr 26, 2023
              Special5%0.5Jun 30, 2022Apr 28, 2022
              Final5%0.5Jun 30, 2022Apr 27, 2022
              Final5%0.5Jul 16, 2019Apr 24, 2019
            • All TypesEx-DateRecord DateAnnounced onDetails
              BonusJun 11, 2019Jun 12, 2019Apr 24, 2019Bonus Ratio: 1 share(s) for every 1 shares held

            About Syngene Int.

            Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 29,425.49 Crore) operating in Pharmaceuticals sector. Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue and Scrap for the year ending 31-Mar-2024. Show More

            • Executives

            • Auditors

            • KM

              Kiran Mazumdar Shaw

              Non Executive Chairman
              JH

              Jonathan Hunt

              Managing Director & CEO
              SB

              Sibaji Biswas

              Executive Director & CFO
              CR

              Catherine Rosenberg

              Non Executive Director
              Show More
            • B S R & Co. LLP

            Industry

            Pharma - Indian

            Key Indices Listed on

            Nifty Midcap 100, Nifty 200, Nifty 500, + 20 more

            Address

            Biocon SEZ, Biocon Park,Plot No. 2 & 3,Bengaluru, Karnataka - 560099

            Contact

            [email protected]

            http://www.syngeneintl.com

            More Details

            FAQs about Syngene Int. share

            • 1. What's the Syngene Int. share price today?
              Syngene Int. share price was Rs 731.95 as on 05 Jul, 2024, 03:57 PM IST. Syngene Int. share price was up by 0.86% based on previous share price of Rs 718.15. Syngene Int. share price trend:
              • Last 1 Month: Syngene Int. share price moved up by 8.99%
              • Last 3 Months: Syngene Int. share price moved up by 0.34%
              • Last 12 Months: Syngene Int. share price moved down 3.05%
              • Last 3 Years: Syngene Int. Share price moved up by 24.60%
            • 2. What is the CAGR of Syngene Int.?
              The CAGR of Syngene Int. is 12.42.
            • 3. What is the PE & PB ratio of Syngene Int.?
              The PE ratio of Syngene Int. stands at 57.11, while the PB ratio is 6.84.
            • 4. What are the key metrics to analyse Syngene Int. Share Price?
              Syngene Int. share can be quickly analyzed on following metrics:
              • Stock's PE is 57.70
              • Price to Book Ratio of 6.85
            • 5. Who's the chairman of Syngene Int.?
              Kiran Mazumdar Shaw is the Non Executive Chairman of Syngene Int.
            • 6. What is 52 week high/low of Syngene Int. share price?
              In last 52 weeks Syngene Int. share had a high price of Rs 860.25 and low price of Rs 607.65
            • 7. What is the market cap of Syngene Int.?
              Within the Pharmaceuticals sector, Syngene Int. stock has a market cap rank of 17. Syngene Int. has a market cap of Rs 29,425.49 Cr.
            • 8. Who are the key owners of Syngene Int. stock?
              Promoter,DII and FII owns 54.79, 14.62 and 21.2 shares of Syngene Int. as on 31 Mar 2024
              • There is no change in promoter holding from 31 Dec 2023 to 31 Mar 2024
              • Domestic Institutional Investors holding has gone up from 14.62 (31 Dec 2023) to 15.78 (31 Mar 2024)
              • Foreign Institutional Investors holding have gone down from 21.2 (31 Dec 2023) to 20.91 (31 Mar 2024)
              • Other investor holding have gone down from 9.39 (31 Dec 2023) to 8.51 (31 Mar 2024)
            • 9. Who are the peers for Syngene Int. in Pharmaceuticals sector?
              Top 10 Peers for Syngene Int. are Ipca Laboratories Ltd., Ajanta Pharma Ltd., Gland Pharma Ltd., J B Chemicals & Pharmaceuticals Ltd., Aarti Industries Ltd., Laurus Labs Ltd., Natco Pharma Ltd., Glenmark Pharmaceuticals Ltd., Piramal Pharma Ltd. and Suven Pharmaceuticals Ltd.
            • 10. What are the Syngene Int. quarterly results?
              Total Revenue and Earning for Syngene Int. for the year ending 2024-03-31 was Rs 3579.20 Cr and Rs 510.00 Cr on Consolidated basis. Last Quarter 2024-03-31, Syngene Int. reported an income of Rs 933.00 Cr and profit of Rs 188.60 Cr.
            • 11. Who is the Chief Executive Officer of Syngene Int.?
              Jonathan Hunt is the Managing Director & CEO of Syngene Int.
            • 12. What are the returns for Syngene Int. share?
              Return Performance of Syngene Int. Shares:
              • 1 Week: Syngene Int. share price moved up by 3.09%
              • 1 Month: Syngene Int. share price moved up by 8.99%
              • 3 Month: Syngene Int. share price moved up by 0.34%
              • 6 Month: Syngene Int. share price moved up by 1.15%
            • 13. Is Syngene Int. giving dividend?
              An equity Final dividend of Rs 1.25 per share was declared by Syngene International Ltd. on 24 Apr 2024. So, company has declared a dividend of 12% on face value of Rs 10 per share. The ex dividend date was 28 Jun 2024.

            Trending in Markets

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Syngene Int. Share Price
            The Economic Times